Back to News
Market Impact: 0.3

Ardelyx, Inc. Reports Third Quarter 2026 Financial Results

Source: Nasdaq

Corporate EarningsCompany FundamentalsHealthcare & Biotech

Ardelyx reported third-quarter 2026 product revenue of $125.5 million, up 19% from $105.5 million in the third quarter of 2025. IBSRELA contributed $96.3 million; the provided article text does not include further results or guidance.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.30

Ticker Sentiment

ARDX0.45

More News

From AllMind Research

Browse all research